Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Peking University synthesizes novel agents to treat cancer

Nov. 10, 2011

New tranylcypromine derivatives designed in Italy

Nov. 10, 2011

Novel antitumor compound prepared at Chinese university

Nov. 10, 2011

Enrollment begins in Genetech's phase II GDC-0980 trial in endometrial cancer

Nov. 10, 2011

Recommended phase II dose of serdemetan determined in patients with advanced solid tumors

Nov. 10, 2011

Aspirin lowers risk of colorectal cancer in Lynch syndrome

Nov. 10, 2011

FDA accepts NDA for vismodegib

Nov. 9, 2011

FDA approves Erbitux for new indication

Nov. 9, 2011

University of North Carolina team patents novel anisamide-oligonucleotide conjugates

Nov. 9, 2011

Novel kinesin-like protein KIF11 inhibitors presented

Nov. 9, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...